BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

226 related articles for article (PubMed ID: 30910913)

  • 1. Pathogenic variants in the AFG3L2 proteolytic domain cause SCA28 through haploinsufficiency and proteostatic stress-driven OMA1 activation.
    Tulli S; Del Bondio A; Baderna V; Mazza D; Codazzi F; Pierson TM; Ambrosi A; Nolte D; Goizet C; Toro C; Baets J; Deconinck T; DeJonghe P; Mandich P; Casari G; Maltecca F
    J Med Genet; 2019 Aug; 56(8):499-511. PubMed ID: 30910913
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Sustained OMA1-mediated integrated stress response is beneficial for spastic ataxia type 5.
    Franchino CA; Brughera M; Baderna V; De Ritis D; Rocco A; Seneca S; Regal L; Podini P; D'Antonio M; Toro C; Quattrini A; Scalais E; Maltecca F
    Brain; 2024 Mar; 147(3):1043-1056. PubMed ID: 37804316
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mice harbouring a SCA28 patient mutation in AFG3L2 develop late-onset ataxia associated with enhanced mitochondrial proteotoxicity.
    Mancini C; Hoxha E; Iommarini L; Brussino A; Richter U; Montarolo F; Cagnoli C; Parolisi R; Gondor Morosini DI; Nicolò V; Maltecca F; Muratori L; Ronchi G; Geuna S; Arnaboldi F; Donetti E; Giorgio E; Cavalieri S; Di Gregorio E; Pozzi E; Ferrero M; Riberi E; Casari G; Altruda F; Turco E; Gasparre G; Battersby BJ; Porcelli AM; Ferrero E; Brusco A; Tempia F
    Neurobiol Dis; 2019 Apr; 124():14-28. PubMed ID: 30389403
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Loss of Mitochondrial AAA Proteases AFG3L2 and YME1L Impairs Mitochondrial Structure and Respiratory Chain Biogenesis.
    Cesnekova J; Rodinova M; Hansikova H; Zeman J; Stiburek L
    Int J Mol Sci; 2018 Dec; 19(12):. PubMed ID: 30544562
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Concurrent AFG3L2 and SPG7 mutations associated with syndromic parkinsonism and optic atrophy with aberrant OPA1 processing and mitochondrial network fragmentation.
    Magri S; Fracasso V; Plumari M; Alfei E; Ghezzi D; Gellera C; Rusmini P; Poletti A; Di Bella D; Elia AE; Pantaleoni C; Taroni F
    Hum Mutat; 2018 Dec; 39(12):2060-2071. PubMed ID: 30252181
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Spinocerebellar Ataxia Type 28-Phenotypic and Molecular Characterization of a Family with Heterozygous and Compound-Heterozygous Mutations in AFG3L2.
    Tunc S; Dulovic-Mahlow M; Baumann H; Baaske MK; Jahn M; Junker J; Münchau A; Brüggemann N; Lohmann K
    Cerebellum; 2019 Aug; 18(4):817-822. PubMed ID: 31111429
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A novel AFG3L2 mutation close to AAA domain leads to aberrant OMA1 and OPA1 processing in a family with optic atrophy.
    Baderna V; Schultz J; Kearns LS; Fahey M; Thompson BA; Ruddle JB; Huq A; Maltecca F
    Acta Neuropathol Commun; 2020 Jun; 8(1):93. PubMed ID: 32600459
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Whole-exome sequencing identifies homozygous AFG3L2 mutations in a spastic ataxia-neuropathy syndrome linked to mitochondrial m-AAA proteases.
    Pierson TM; Adams D; Bonn F; Martinelli P; Cherukuri PF; Teer JK; Hansen NF; Cruz P; Mullikin For The Nisc Comparative Sequencing Program JC; Blakesley RW; Golas G; Kwan J; Sandler A; Fuentes Fajardo K; Markello T; Tifft C; Blackstone C; Rugarli EI; Langer T; Gahl WA; Toro C
    PLoS Genet; 2011 Oct; 7(10):e1002325. PubMed ID: 22022284
    [TBL] [Abstract][Full Text] [Related]  

  • 9. m-AAA and i-AAA complexes coordinate to regulate OMA1, the stress-activated supervisor of mitochondrial dynamics.
    Consolato F; Maltecca F; Tulli S; Sambri I; Casari G
    J Cell Sci; 2018 Apr; 131(7):. PubMed ID: 29545505
    [TBL] [Abstract][Full Text] [Related]  

  • 10. m-AAA proteases, mitochondrial calcium homeostasis and neurodegeneration.
    Patron M; Sprenger HG; Langer T
    Cell Res; 2018 Mar; 28(3):296-306. PubMed ID: 29451229
    [TBL] [Abstract][Full Text] [Related]  

  • 11. ATPase Domain AFG3L2 Mutations Alter OPA1 Processing and Cause Optic Neuropathy.
    Caporali L; Magri S; Legati A; Del Dotto V; Tagliavini F; Balistreri F; Nasca A; La Morgia C; Carbonelli M; Valentino ML; Lamantea E; Baratta S; Schöls L; Schüle R; Barboni P; Cascavilla ML; Maresca A; Capristo M; Ardissone A; Pareyson D; Cammarata G; Melzi L; Zeviani M; Peverelli L; Lamperti C; Marzoli SB; Fang M; Synofzik M; Ghezzi D; Carelli V; Taroni F
    Ann Neurol; 2020 Jul; 88(1):18-32. PubMed ID: 32219868
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Regulation of OPA1 processing and mitochondrial fusion by m-AAA protease isoenzymes and OMA1.
    Ehses S; Raschke I; Mancuso G; Bernacchia A; Geimer S; Tondera D; Martinou JC; Westermann B; Rugarli EI; Langer T
    J Cell Biol; 2009 Dec; 187(7):1023-36. PubMed ID: 20038678
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Unique Structural Features of the Mitochondrial AAA+ Protease AFG3L2 Reveal the Molecular Basis for Activity in Health and Disease.
    Puchades C; Ding B; Song A; Wiseman RL; Lander GC; Glynn SE
    Mol Cell; 2019 Sep; 75(5):1073-1085.e6. PubMed ID: 31327635
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Respiratory dysfunction by AFG3L2 deficiency causes decreased mitochondrial calcium uptake via organellar network fragmentation.
    Maltecca F; De Stefani D; Cassina L; Consolato F; Wasilewski M; Scorrano L; Rizzuto R; Casari G
    Hum Mol Genet; 2012 Sep; 21(17):3858-70. PubMed ID: 22678058
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Astrocyte-specific deletion of the mitochondrial m-AAA protease reveals glial contribution to neurodegeneration.
    Murru S; Hess S; Barth E; Almajan ER; Schatton D; Hermans S; Brodesser S; Langer T; Kloppenburg P; Rugarli EI
    Glia; 2019 Aug; 67(8):1526-1541. PubMed ID: 30989755
    [TBL] [Abstract][Full Text] [Related]  

  • 16. AFG3L2 supports mitochondrial protein synthesis and Purkinje cell survival.
    Almajan ER; Richter R; Paeger L; Martinelli P; Barth E; Decker T; Larsson NG; Kloppenburg P; Langer T; Rugarli EI
    J Clin Invest; 2012 Nov; 122(11):4048-58. PubMed ID: 23041622
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mitochondrial stress response triggered by defects in protein synthesis quality control.
    Richter U; Ng KY; Suomi F; Marttinen P; Turunen T; Jackson C; Suomalainen A; Vihinen H; Jokitalo E; Nyman TA; Isokallio MA; Stewart JB; Mancini C; Brusco A; Seneca S; Lombès A; Taylor RW; Battersby BJ
    Life Sci Alliance; 2019 Feb; 2(1):. PubMed ID: 30683687
    [TBL] [Abstract][Full Text] [Related]  

  • 18. SCA28: Novel Mutation in the AFG3L2 Proteolytic Domain Causes a Mild Cerebellar Syndrome with Selective Type-1 Muscle Fiber Atrophy.
    Svenstrup K; Nielsen TT; Aidt F; Rostgaard N; Duno M; Wibrand F; Vinther-Jensen T; Law I; Vissing J; Roos P; Hjermind LE; Nielsen JE
    Cerebellum; 2017 Feb; 16(1):62-67. PubMed ID: 26868664
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Expanding the phenotype of AFG3L2 mutations: Late-onset autosomal recessive spinocerebellar ataxia.
    Chiang HL; Fuh JL; Tsai YS; Soong BW; Liao YC; Lee YC
    J Neurol Sci; 2021 Sep; 428():117600. PubMed ID: 34333379
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Purkinje neuron Ca2+ influx reduction rescues ataxia in SCA28 model.
    Maltecca F; Baseggio E; Consolato F; Mazza D; Podini P; Young SM; Drago I; Bahr BA; Puliti A; Codazzi F; Quattrini A; Casari G
    J Clin Invest; 2015 Jan; 125(1):263-74. PubMed ID: 25485680
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.